Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Streptococcus pneumoniae serotype 9V capsular polysaccharide antigen is a complex carbohydrate molecule located on the surface of S. pneumoniae bacteria, composed of repeating sugar units with distinct structure and modifications (notably 6-O-acetylation of βManNAc via the wcjE gene). This capsule component is a critical virulence factor, protecting the pathogen from host immune mechanisms such as opsonization and phagocytosis, and is the primary target for antibody-mediated immunity induced by several pneumococcal vaccines. The 9V polysaccharide is included as an antigen in both plain polysaccharide and conjugate vaccine formulations, boosting serotype-specific immune responses to prevent invasive pneumococcal diseases. Protection by this molecule is strictly serotype-specific, and changes in serotype prevalence in response to vaccine usage represent a significant therapeutic challenge. Capsule antigens like 9V are not conventional "receptors" or enzymes but serve as distinct therapeutic targets for vaccine-induced immunity, forming the basis for the prevention of S. pneumoniae infections.
Induction of actively acquired immunity: Vaccines containing the 9V capsular polysaccharide induce the production of specific antibodies that opsonize and facilitate clearance of S. pneumoniae serotype 9V from the host. In conjugate vaccines: Conjugation of the polysaccharide to a carrier protein (e.g., CRM197, a non-toxic mutant of diphtheria toxin) converts the response from T cell–independent to T cell–dependent, inducing immunological memory and enhancing efficacy especially in children.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus pneumoniae serotype 9V capsular polysaccharide antigen (No widely recognized abbreviation; sometimes referred to as S. pneumoniae 9V CPS or PPS 9V in scientific literature, but usage is variable and not standardized).